Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of Dysport for adult lower limb spasticity after stroke or traumatic brain injury
2009-015868-34Phase 3Completed
- Sponsor
- Ipsen
- Start
- Dec 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in lower extremity spasticity comparing Dysport with Placebo (2 arms). Primary endpoint: Mean change from baseline in gastrocnemius-soleus complex muscle tone. Started Dec 2010; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
lower extremity spasticity
Beyond the preview
Go deeper on 2009-015868-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015868-34.